| Literature DB >> 25382489 |
Xuemei Han1, Yueju Wang, Aaron Aslanian, Bryan Fonslow, Beth Graczyk, Trisha N Davis, John R Yates.
Abstract
Intact protein analysis via top-down mass spectrometry (MS) provides a bird's eye view over the protein complexes and complex protein mixtures with the unique capability of characterizing protein variants, splice isoforms, and combinatorial post-translational modifications (PTMs). Here we applied capillary electrophoresis (CE) through a sheathless CE-electrospray ionization interface coupled to an LTQ Velos Orbitrap Elite mass spectrometer to analyze the Dam1 complex from Saccharomyces cerevisiae. We achieved a 100-fold increase in sensitivity compared to a reversed-phase liquid chromatography coupled MS analysis of recombinant Dam1 complex with a total loading of 2.5 ng (12 amol). N-terminal processing forms of individual subunits of the Dam1 complex were observed as well as their phosphorylation stoichiometry upon Mps1p kinase treatment.Entities:
Keywords: capillary electrophoresis; phosphorylation site mapping; phosphorylation stoichiometry; post-translational modification; protein complexes; top-down mass spectrometry
Mesh:
Substances:
Year: 2014 PMID: 25382489 PMCID: PMC4262260 DOI: 10.1021/pr500971h
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466
Figure 1(A) Electropherogram of Dam1 complex subunit separation by sheathless CESI–MS (2.5 ng loaded). CE separation conditions: PEI coated capillary; voltage −30 kV; BGE 5% acetic acid, 5% IPA. (B) Chromatogram of Dam1 complex subunit separation by RPLC–MS (250 ng loaded). RPLC separation conditions: 75 um i.d. capillary with 5 μm 1000 Å PSDVB resin; flow rate of 300 nL/min. For more details see Methods and Materials section. (C) Representative MS precursor scans of the 10 protein subunits from Dam1 complex. Subunits 1–9 are from (A) the CESI–MS experiment; subunit 10 is from (B) the RPLC–MS experiment. The insert is the zoomed-in spectrum for Spc19p, showing two different protein envelopes that represent the sequence predicted form (indicated by ○, 18 909 Da, average mass) and the N-terminal methionine excision form (indicated by □, 18 778 Da, average mass).
Intact Molecular Weight Measurements of Dam1 Complex Subunits Using Orbitrap Elite and Calculated Phosphorylation Stoichiometry upon in Vitro Mps1p Treatment. All Mass Values in This Table Are Monoisotopic Masses
| observed mass (Da) | phosphorylation stoichiometry | |||||||
|---|---|---|---|---|---|---|---|---|
| protein | accession | untreated sample | Mpslp treated sample | theoretical mass (Da) | Δmass (ppm) | distribution of phosphorylation states | average phosphorylation stoichiometry | |
| Hsk3 | P69852 | 8082.998 | 8082.998 | 8083.006 | –1.0 | |||
| 7951.970 (-Met) | 7951.970 (-Met) | 7951.966 | 0.6 | |||||
| Dad4 | P69851 | 8150.194 | 8150.194 | 8150.200 | –0.7 | |||
| Dad1 | Q12248 | 10509.18 | 10509.18 | 10509.19 | –1.0 | 0P | 90% | 0.10 |
| 10551.18 (Ac) | 10551.18 (Ac) | 10551.20 | –2.0 | |||||
| 10589.14 (P) | 10589.16 | –1.5 | 1P | 10% | ||||
| 10631.14 (Ac, P) | 10631.17 | –2.5 | ||||||
| Dad3 | P69850 | 10841.62 | 10841.62 | 10841.63 | –0.9 | |||
| Dad2 | P36162 | 15062.26 | 15062.26 | 15062.29 | –2.0 | |||
| Spc19 | Q03954 | 18766.59 (-Met) | 18766.59 (-Met) | 18766.61 | –1.0 | 0P | 100% | ≪ 0.01 |
| 18897.57 | 18897.57 | 18897.65 | –4.2 | |||||
| 18846.60 (-Met) | 18846.58 | 1.3 | 1P | |||||
| Duo1 | P53168 | 27367.08 (-Met, Ac) | 27367.17 | –3.3 | ||||
| 27447.14 (-Met, AC, P) | 27447.14 | 0.1 | 1P | 5% | 2.85 | |||
| 27527.10 (-Met, AC, 2P) | 27527.10 | –0.1 | 2P | 27% | ||||
| 27607.07(-Met, AC, 3P) | 27607.07 | 0.0 | 3P | 47% | ||||
| 27687.03 (-Met, AC, 4P) | 27687.04 | –0.2 | 4P | 20% | ||||
| 27767.08 (-Met, AC, 5P) | 27767.00 | 2.8 | 5P | 1% | ||||
| 27847.08 (-Met, AC, 6P) | 27846.97 | 4.0 | 6P | 4.71 | ||||
| Ask1 | P35734 | 32052.23 | 32052.20 | 1.0 | ||||
| 32212.14 (2P) | 32212.13 | 0.2 | 2P | |||||
| 32292.04 (3P) | 32292.10 | –1.8 | 3P | 12% | ||||
| 32372.20 (4P) | 32372.07 | 4.2 | 4P | 33% | ||||
| 32452.14 (5P) | 32452.03 | 3.3 | 5P | 34% | ||||
| 32531.87 (6P) | 32532.00 | –3.9 | 6P | 16% | ||||
| 32612.05 (7P) | 32611.96 | 2.6 | 7P | 6% | ||||
| 32691.81 (8P) | 32691.93 | –3.7 | 8P | |||||
| Spc34–6XHis | P36131 | 34747.85 (-Met) | 34747.85 (-Met) | 34747.89 | –1.2 | 0P | 54% | 0.31 |
| 34827.90 (-Met, P) | 34827.86 | 1.2 | 1P | 35% | ||||
| 34907.88 (-Met, 2P) | 34907.82 | 1.6 | 2P | 11% | ||||
| Dam1 | P53267 | 38267.38 (-Met) | 38267.41 | –0.8 | 5.85 | |||
| 38507.24 (-Met, 3P) | 38507.31 | –1.8 | 3P | |||||
| 38587.41 (-Met, 4P) | 38587.27 | 3.5 | 4P | 15% | ||||
| 38667.19 (-Met, 5P) | 38667.24 | –1.3 | 5P | 23% | ||||
| 38747.25 (-Met, 6P) | 38747.21 | 1.1 | 6P | 35% | ||||
| 38826.98 (-Met, 7P) | 38827.17 | –5.0 | 7P | 17% | ||||
| 38907.09 (-Met, 8P) | 38907.14 | –1.3 | 8P | 10% | ||||
| 38987.16 (-Met, 9P) | 38987.11 | 1.4 | 9P | |||||
MS1 spectra detected but EIE peak cannot be extracted due to the low abundance, resulting in too few data points for constructing an EIE peak accurately.
Figure 2Comparison of the phosphorylation states of untreated Dam1 complex subunits (A) Dad1p and (C) Duo1p, and Mps1p kinase-treated Dam1 complex subunits (B) Dad1p and (D) Duo1p on selected charge states. The phosphorylated proteoforms were labeled with #P, where # is the number of phosphorylation states.
Figure 3EIEs of the four major phosphorylation forms (1P, 2P, 3P, 4P at charge state 36+) for Duo1p following in vitro Mps1p kinase treatment. The MS detection was done with LTQ full scan mode, and the window of ±0.2 amu was used for peak extraction. The integrated peak areas were used for phosphorylation stoichiometry calculations in Table 1.
Figure 4CID fragmentation of selected precursor ion (1178.139+) and protein identification along with the fragmentation map for Dad1p (measured MW = 10 589.14 Da). The MS/MS spectrum corresponded to the identification of Dad1p with one phosphorylation site (T87, in red) localized. The b- and y-ions were indicated as blue and red in the fragmentation map and the MS/MS spectrum.
Identified Phosphorylation Sites on Dam1 Complex Subunits Following 90 min in Vitro Treatment With Mps1p. Combined Results from Top-Down, Bottom-Up, Middle-Down Experiments
| protein name | number of phosphorylated states indicated by intact MW detection | number of phosphorylation sites identified | phosphorylation sites identified |
|---|---|---|---|
| Dad1 | 1 | 1 (0) | |
| Spc19 | 1 | 1 (0) | |
| Duo1 | 6 | 3 (6) | (S10/T11) |
| Ask1 | 8 | 11 (7) | (S56/T57); |
| Spc34 | 2 | 2 (0) | |
| Dam1 | 9 | 10 (8) |
Identified by top-down MS/MS experiments only.
Identified by middle-down experiments only. Numbers in the third column are localized phosphorylation sites with additional number of poorly localized sites in parentheses. Identified phosphorylation sites in bold are localized phosphorylation sites; poorly localized sites are in parentheses.